Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Xencor Inc (NASDAQ:XNCR)

22.26
Delayed Data
As of 2:06pm ET
 -0.13 / -0.58%
Today’s Change
9.00
Today|||52-Week Range
24.82
+38.78%
Year-to-Date
No recent news for Xencor Inc.

Today’s Trading

Previous close22.39
Today’s open21.41
Day’s range21.41 - 22.82
Volume81,869
Average volume (3 months)236,038
Market cap$903.6M
Dividend yield--
Data as of 2:06pm ET, 08/03/2015

Growth & Valuation

Earnings growth (last year)+86.49%
Earnings growth (this year)-39.42%
Earnings growth (next 5 years)--
Revenue growth (last year)-6.41%
P/E ratioNM
Price/Sales52.89
Price/Book11.87

Competitors

 Today’s
change
Today’s
% change
SGYPSynergy Pharmaceutic...-0.21-2.25%
EPZMEpizyme Inc-0.70-3.14%
TGTXTG Therapeutics Inc+0.28+1.60%
NWBONorthwest Biotherape...-0.22-1.93%
Data as of 2:17pm ET, 08/03/2015

Financials

Next reporting dateAugust 5, 2015
EPS forecast (this quarter)-$0.18
Annual revenue (last year)$9.5M
Annual profit (last year)-$16.4M
Net profit margin-172.50%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Bassil I. Dahiyat
Vice President-Finance &
Investor Relations
John J. Kuch
Corporate headquarters
Monrovia, California

Forecasts